Inogen Inc — Director's Dealing 2025

Mar 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2025-02-28

Reporting Person: Smith Kevin Raymond Merrill (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-01	Common Stock	A	1500	$8.33	Acquired	16054	Direct
2025-03-01	Common Stock	M	28333	—	Acquired	44387	Direct
2025-03-01	Common Stock	F	13700	$8.33	Disposed	30687	Direct
2025-03-01	Common Stock	A	53975	—	Acquired	84662	Direct
2025-03-01	Common Stock	F	26097	$8.33	Disposed	58565	Direct
2025-03-03	Common Stock	P	11709	$8.5614	Acquired	70274	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-28	Restricted Stock Unit	$	A	90036	Acquired		Common Stock (90036)	Direct
2025-03-01	Restricted Stock Unit	$	M	28333	Disposed		Common Stock (28333)	Direct

Footnotes

F1: Shares acquired through the Company's 2014 Employee Stock Purchase Plan.

F2: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with a portion of a time-based restricted stock unit award that vested on March 1, 2025.

F3: The reported securities represent shares earned and vested on March 1, 2025 based on achievement of the financial performance conditions for the 2024 fiscal year that were approved as part of the 2023 performance-based restricted stock unit award granted on November 10, 2023.

F4: The reported shares were withheld to cover the reporting person's tax withholding liability in connection with the 2023 performance-based restricted stock unit award granted on November 10, 2023 and vested on March 1, 2025.

F5: Represents the weighted average share price of an aggregate total of 11,709 shares sold in the price range of $8.455 to $8.6298 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F6: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F7: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.

F8: 1/3rd of the restricted stock units vested on March 1, 2025 (the "2025 Vesting Commencement Date"), and subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the 2025 Vesting Commencement Date.